← Back to Clinical Trials
Recruiting NCT06133595

NCT06133595 Mi Bridge - Motivational Interviewing to Facilitate Help-seeking Among Individuals with Sexual Interest in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06133595
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Child Sexual Abuse
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-09-18
Primary Completion 2024-10-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Behavioral: MiBridge

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2023-09-18 with a primary completion date of 2024-10-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overall aim of the study is to evaluate the effectiveness of Mi Bridge to motivate high risk participants to admit to treatment. The main research question is: Is Mi Bridge, an anonymous online program based on the principles for Motivational Interviewing, effective in making high risk individuals for committing child sexual abuse prone to seek treatment for problems related to sexual interest involving children at a health care facility?

Eligibility Criteria

Inclusion Criteria: * Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish * Concerns about sexual interest regarding children * CSAM use past six month * High risk for committing child sexual abuse according to the SChiMRA scale Exclusion Criteria: * Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious intentions to participate.

Contact & Investigator

Central Contact

Christoffer Rahm, MD, PhD

✉ christoffer.rahm@ki.se

📞 +46793393723

Frequently Asked Questions

Who can join the NCT06133595 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Child Sexual Abuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06133595 currently recruiting?

Yes, NCT06133595 is actively recruiting participants. Contact the research team at christoffer.rahm@ki.se for enrollment information.

Where is the NCT06133595 trial being conducted?

This trial is being conducted at Klecany, Czechia, Helsinki, Finland, Hamburg, Germany, Bratislava, Slovakia and 2 additional locations.

Who is sponsoring the NCT06133595 clinical trial?

NCT06133595 is sponsored by Karolinska Institutet. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology